Company Description

BiomX Inc., a holding company, focuses on defense, security, and critical infrastructure technologies.

The company’s portfolio targets various niches, such as counter‑drone systems, AI-enabled command-and-control, perimeter and border security, wide-area surveillance, and aerial firefighting.

It serves defense agencies, prime contractors, transportation operators, municipalities, and critical infrastructure providers.

The company was founded in 2015 and is based in Dover, Delaware.

BiomX Inc.

Country	United States
Founded	2015
Industry	Aerospace & Defense
Sector	Industrials
Employees	20
CEO	Michael Oster

Contact Details

Address: 850 New Burton Road, Suite 201 Dover, Delaware 19904 United States
Website	biomx.com

Stock Details

Ticker Symbol	PHGE
Exchange	NYSEAMERICAN
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	1739174
CUSIP Number	09090D103
ISIN Number	US09090D5095
Employer ID	82-3364020
SIC Code	2836

Key Executives

Name	Position
Michael Oster	Chief Executive Officer and Director
Marina Wolfson CPA	Secretary
Prof. Rotem Sorek Ph.D.	Scientific Founder
Dr. Eran Elinav M.D., Ph.D.	Scientific Founder
Dr. Timothy K. Lu M.D., Ph.D.	Scientific Founder
Dr. Carl R. Merril M.D.	Scientific Founder
David Rokach	Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer
Roy Timor-Rousso	Chief Business Officer

Latest SEC Filings

Date	Type	Title
Jun 26, 2026	8-K	Current Report
Jun 22, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Jun 18, 2026	8-K	Current Report
Jun 16, 2026	SCHEDULE 13D/A	Filing
Jun 16, 2026	424B5	Filing
Jun 12, 2026	8-K	Current Report
Jun 12, 2026	8-K/A	[Amend] Current report
Jun 8, 2026	DEF 14A	Other definitive proxy statements
Jun 5, 2026	8-K	Current Report
May 28, 2026	SCHEDULE 13D/A	Filing

View All SEC Filings